NSIS B logo

Novozymes A/S Stock Price

CPSE:NSIS B Community·DKK 173.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 32 Fair Values set on narratives written by author

NSIS B Share Price Performance

DKK 372.80
-56.50 (-13.16%)
DKK 560.00
Fair Value
DKK 372.80
-56.50 (-13.16%)
33.4% undervalued intrinsic discount
DKK 560.00
Fair Value
Price DKK 372.80
AnalystHighTarget DKK 560.00
AnalystLowTarget DKK 380.00
AnalystConsensusTarget DKK 471.06

NSIS B Community Narratives

AnalystHighTarget·
Fair Value DKK 560 33.4% undervalued intrinsic discount

Emerging Markets And Biofuels Will Support A Stronger Long Term Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value DKK 380 1.9% undervalued intrinsic discount

Bioenergy And Biosolutions Demand Will Support Earnings Despite Regulatory And Competitive Headwinds

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·
Fair Value DKK 471.06 20.9% undervalued intrinsic discount

Enzyme Biosolutions And Preventive Health Trends Will Drive Long-Term Expansion

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
DKK 560
33.4% undervalued intrinsic discount
Revenue
8.35% p.a.
Profit Margin
18.57%
Future PE
51.7x
Price in 2029
DKK 802.76
DKK 380
1.9% undervalued intrinsic discount
Revenue
6.12% p.a.
Profit Margin
19.32%
Future PE
35.9x
Price in 2028
DKK 447.87
DKK 471.06
20.9% undervalued intrinsic discount
Revenue
6.83% p.a.
Profit Margin
18.91%
Future PE
44.56x
Price in 2028
DKK 555.11

Trending Discussion

Updated Narratives

NSIS B logo

Emerging Markets And Biofuels Will Support A Stronger Long Term Outlook

Fair Value: DKK 560 33.4% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NSIS B logo

Bioenergy And Biosolutions Demand Will Support Earnings Despite Regulatory And Competitive Headwinds

Fair Value: DKK 380 1.9% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NSIS B logo

Enzyme Biosolutions And Preventive Health Trends Will Drive Long-Term Expansion

Fair Value: DKK 471.06 20.9% undervalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Solid track record with adequate balance sheet and pays a dividend.

1 Risk
4 Rewards

Novozymes A/S Key Details

€4.2b

Revenue

€1.9b

Cost of Revenue

€2.3b

Gross Profit

€1.7b

Other Expenses

€583.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 05, 2026
1.25
55.45%
14.04%
25.9%
View Full Analysis

About NSIS B

Founded
n/a
Employees
11098
CEO
Ester Baiget
WebsiteView website
www.novonesis.com

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women’s, children’s cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.

Recent NSIS B News & Updates

Recent updates

No updates

Novozymes A/S Competitors